• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PAA
Click for more information
6.25% 17.0¢

PHARMAUST LIMITED

Market Cap $82.65M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

PharmAust Limited is a clinical-stage biotechnology company developing therapeutics for... PharmAust Limited is a clinical-stage biotechnology company developing therapeutics for human and animal health applications. The Company’s segments include Corporate and Research. The Company is focused on repurposing monepantel (MPL) for human neurodegenerative diseases. The Company's lead candidate, Monepantel (MPL), is a potent and safe inhibitor of the mTOR pathway, that plays a central role in cell growth and proliferation of cancer cells and in degenerating neurons. The Company is also developing MPL as a treatment for motor neuron disease (MND/ALS), a rare, incurable disease. It is focused on starting Phase II/III clinical study of MPL. It has also completed a Phase II oncology clinical study of MPL in humans and pilot studies in canine cancer. It is also preparing a pivotal monepantel field trial in dogs with B-Cell Lymphoma to enable product registration in the United States.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PAA
Pitney Pharmaust patents valuation - Kpax 		15:07 23 4.0K
15:07 Last post  Grainofsand Comments Created with Sketch.  23  Views Created with Sketch.  4.0K 
PAA
PAA - General discussions 		09:46 33 7.9K
09:46 Last post  Grainofsand Comments Created with Sketch.  33  Views Created with Sketch.  7.9K 
PAA
Pharmaust - Media & News
2
06:10 110 38K
06:10 Last post  Cashtrain Comments Created with Sketch.  110  Views Created with Sketch.  38K 
PAA
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
2 3 4
01:38 202 50K
01:38 Last post  Jakjazz Comments Created with Sketch.  202  Views Created with Sketch.  50K 
PAA
Extraordinary results 		18/08/24 5 2.4K
18/08/24 Last post  volvoman Comments Created with Sketch.  5  Views Created with Sketch.  2.4K 
PAA
Oversold x5 		16/08/24 28 7.1K
16/08/24 Last post  Peeteepoo Comments Created with Sketch.  28  Views Created with Sketch.  7.1K 
PAA
Ann: OLE Study update reveals impressive Survival Data
3 4 5
13/08/24 248 67K
13/08/24 Last post  NZ Trader Comments Created with Sketch.  248  Views Created with Sketch.  67K 
PAA
Latest MND Webinar information on Monepantel 		09/08/24 33 8.4K
09/08/24 Last post  Lastly Comments Created with Sketch.  33  Views Created with Sketch.  8.4K 

See All Discussions arrow Created with Sketch.

Timeline

AGM Date & Director Nominations Closing Date for AGM
05 Aug 08:38
 
Section 708A Cleansing Statement
30 Jul 16:39
 
Application for quotation of securities - PAA
30 Jul 16:34
 
Appendix 4C & Quarterly Update
29 Jul 09:38
 
Change of Director's Interest Notices x2
29 Jul 08:42
 
Application for quotation of securities - PAA
25 Jul 08:26
 
View More arrow Created with Sketch.

Featured News

RDN Raiden Resources hopeful it can start drilling Andover South, WA, as early as mid-October
right-arrow Created with Sketch.
SBW Shekel Brainweigh provides key business update ahead of final 2024 quarter
right-arrow Created with Sketch.
NEWS How institutional adoption is shaping the future of crypto
right-arrow Created with Sketch.

(20min delay)
Last
17.0¢ 		Change
0.010(6.25%) 		Mkt cap ! $82.65M
Open High Low Value Volume
16.0¢ 17.0¢ 15.5¢ $145.3K 876.8K

Buyers (Bids)

No. Vol. Price($)
1 38307 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 302337 3
View Market Depth
Last trade - 15.51pm 23/08/2024 (20 minute delay) ?
Last
17.0¢ 		  Change
0.010 ( 6.25 %)
Open High Low Volume
15.8¢ 17.5¢ 15.5¢ 225724
Last updated 15.46pm 23/08/2024 ?
PAA (ASX) Chart

Top Stories

Raiden gears up for exploration in final quarter of 2024

Raiden Resources Ltd - which is exploration for a multiplicity of minerals in the Pilbara region of WA - is looking ahead to a busy schedule.
IPH raises $100M to buy up Canadian IP firm Bereskin & Parr IPH Ltd has raised $100 million in an institutional placement to support the acquisition, while also launching a share purchase plan.
Reporting wrap: Inghams, Accent, Mayne Pharma Inghams Group Ltd, Accent Group Ltd and Mayne Pharma Group Ltd all reported final year results for the 2024 fiscal year.
Week 34 Wrap: HotCopper's top watched; Oz banks cut saver interest; Kamala’s 28% corporate tax; AI’s back This week’s biggest story (in my view) for the Australian economy actually started late last week. Quietly, CBA cut its term deposit interest rates, prompting ANZ and NAB to do the same on Monday of this week.
The Rising Tide: How institutional adoption is shaping the future of crypto This year's institutional demand for Bitcoin supports stability & credibility for the asset class. We look at what's happened since crypto ETFs were approved in the US & what that means for Australian investors.

Featured News

SBW Shekel Brainweigh provides key business update ahead of final 2024 quarter
right-arrow Created with Sketch.
RDN Raiden Resources hopeful it can start drilling Andover South, WA, as early as mid-October
right-arrow Created with Sketch.
NEWS How institutional adoption is shaping the future of crypto
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.